Bright Minds Overview
- Year Founded
-
2017
- Status
-
Public
- Employees
-
25
- Stock Symbol
-
DRUG
- Share Price
-
$22.96
- (As of Friday Closing)
Bright Minds General Information
Description
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Contact Information
Website
www.brightmindsbio.comCorporate Office
- 19 Vestry Street
- New York, NY 10013
- United States
Corporate Office
- 19 Vestry Street
- New York, NY 10013
- United States
Bright Minds Timeline
Bright Minds Stock Performance
As of 13-Nov-2026, Bright Minds’s stock price is $22.96. Its current market cap is $226M with 9.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $22.96 | $23.15 | $18.53 - $123.42 | $226M | 9.9M | 1.01K | -$2.05 |
Bright Minds Financials Summary
As of 30-Jun-2026, Bright Minds has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 30-Sep-2025 | FY 2024 30-Sep-2024 | FY 2023 30-Sep-2023 |
|---|---|---|---|---|
| EV | 486,378 | 393,004 | 285 | 52 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (22,618) | (9,761) | (2,027) | (5,407) |
| Net Income | (17,731) | (8,731) | (2,059) | (5,461) |
| Total Assets | 218,368 | 60,659 | 4,518 | 5,061 |
| Total Debt | 46 | 90 | 88 | 54 |
Bright Minds Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bright Minds Patents
Bright Minds Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023264112-A1 | Azepinoindoles and methods of preparation thereof | Pending | 06-May-2022 | ||
| EP-4519266-A1 | Azepinoindoles and methods of preparation thereof | Pending | 06-May-2022 | ||
| EP-4519266-A4 | Azepinoindoles and methods of preparation thereof | Pending | 06-May-2022 | ||
| US-20250296934-A1 | Azepinoindoles and methods of preparation thereof | Pending | 06-May-2022 | ||
| WO-2023212811-A1 | Azepinoindoles and methods of preparation thereof | Inactive | 06-May-2022 | C07D487/04 |
Bright Minds Signals
Bright Minds ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Bright Minds FAQs
-
When was Bright Minds founded?
Bright Minds was founded in 2017.
-
Where is Bright Minds headquartered?
Bright Minds is headquartered in New York, NY.
-
What is the size of Bright Minds?
Bright Minds has 25 total employees.
-
What industry is Bright Minds in?
Bright Minds’s primary industry is Drug Discovery.
-
Is Bright Minds a private or public company?
Bright Minds is a Public company.
-
What is Bright Minds’s stock symbol?
The ticker symbol for Bright Minds is DRUG.
-
What is the current stock price of Bright Minds?
As of 13-Nov-2026 the stock price of Bright Minds is $22.96.
-
What is the current market cap of Bright Minds?
The current market capitalization of Bright Minds is $226M.
-
What is Bright Minds’s annual earnings per share (EPS)?
Bright Minds’s EPS for 12 months was -$2.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process